Related Experiment Video
Updated: Feb 2, 2026

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
A protective role for microRNA-688 in acute kidney injury
Nicholas Chun1, Steven G Coca1, John Cijiang He1,2
1Department of Medicine/Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Abstract:
Ischemia-reperfusion (I/R) sets off a devastating cascade of events, leading to cell death and possible organ failure. Treatments to limit I/R-associated damage are lacking, and the pathways that drive injury are poorly understood. In this issue of the JCI, Wei and colleagues identify microRNA-668 (miR-668) as a protective factor in acute kidney injury (AKI). miR-668 was shown to repress mitochondrial fission-associated protein MTP18, thereby inhibiting pathogenic mitochondrial fragmentation. In murine models of I/R-induced AKI, treatment with a miR-668 mimetic reduced mitochondrial fragmentation and improved renal function. Moreover, HIF-1α was shown to be required for miR-688 expression in response to I/R. Importantly, Wei et al. show miR-668 upregulation in a cohort of human patients with AKI. Together, these results identify a HIF-1α/miR-668/MTP18 axis that may have potential as a therapeutic target for AKI.
Insights
MicroRNA-668 (miR-668) protects against kidney damage from ischemia-reperfusion injury. This finding reveals a new therapeutic target for acute kidney injury (AKI) by inhibiting mitochondrial fragmentation.
Area of Science:
- Nephrology
- Molecular Biology
- Cellular Biology
Background:
- Ischemia-reperfusion (I/R) injury causes significant cell death and organ failure.
- Current treatments for I/R-associated damage are limited, and underlying injury pathways are not fully understood.
Purpose of the Study:
- To identify novel molecular mechanisms and potential therapeutic targets for acute kidney injury (AKI).
Main Methods:
- Investigated the role of microRNA-668 (miR-668) in murine models of I/R-induced AKI.
- Assessed the effect of miR-668 on mitochondrial fission and renal function.
- Examined the regulatory relationship between Hypoxia-inducible factor 1-alpha (HIF-1α) and miR-668.
- Analyzed miR-668 expression in human AKI patient cohorts.
Main Results:
- miR-668 was identified as a protective factor in I/R-induced AKI.
- miR-668 represses mitochondrial fission protein MTP18, inhibiting pathogenic mitochondrial fragmentation.
- Treatment with a miR-668 mimetic reduced mitochondrial fragmentation and improved kidney function in murine models.
- HIF-1α is essential for miR-668 expression following I/R.
- miR-668 levels were upregulated in human AKI patients.
Conclusions:
- A novel HIF-1α/miR-668/MTP18 signaling axis was identified in AKI.
- This axis represents a potential therapeutic target for mitigating I/R-induced kidney damage.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

